The role of drugs in the treatment of cerebral palsy.

The role of drugs in the treatment of cerebral palsy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The role of drugs in the treatment of cerebral palsy. Abstract Text:

H KABAT,

The role of drugs in the treatment of cerebral palsy. Publishing Authors By Initials

H KABAT,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The role of drugs in the treatment of cerebral palsy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Permanente Foundation medical bulletin

VOLUME: 7

Page Numbers: 37-44

Journal Abbreviation:

ISSN:

DAY: 27

MONTH: Feb

YEAR: 1949

The role of drugs in the treatment of cerebral palsy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 19540420

The role of drugs in the treatment of cerebral palsy. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The role of drugs in the treatment of cerebral palsy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The role of drugs in the treatment of cerebral palsy.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Perm Found Med Bull

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The role of drugs in the treatment of cerebral palsy Related Publications

• A quantitative study of passive anaphylaxis in the guinea pig; the latent period in passive anaphylaxis in its relation to the dose of rabbit antiovalbumin.
• Allergic mechanisms in nervous disease.
• An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations.
• Development of H activity by human blood-group B substance treated with coffee bean alpha-galactosidase.
• Drug therapy of cerebellar ataxia and disorders of the basal ganglia, based on cerebellar-striatal antagonism.
• Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism.
• Immunochemical estimation of the rate of disappearance of transfused gamma globulin from the blood in two cases of hypoproteinemia.
• Immunochemical studies on blood groups; the methylpentose contents of hog and human blood group A and O substances and their relationship to cross-reactivity with type XIV antipneumococcus horse serum.
• Permanente Foundation medical bulletin
• Permanente Foundation medical bulletin
• Permanente Foundation medical bulletin
• Pillars Article: An Analysis of the Sequences of the Variable Regions of Bence Jones Proteins and Myeloma Light Chains and their Implications for Antibody Complementarity. J. Exp. Med. 1970. 132: 211-250.
• REM sleep reduction, mood regulation and remission in untreated depression.
• Size and heterogeneity of the combining sites on an antibody molecule.
• Spasticity; its nature and treatment.
• Sterilizing techniques with ethylene oxide.
• Studies on neuromuscular dysfunction; new principles of neuromuscular reeducation.
• The effect of adrenocorticotrophic hormone and X-ray on the amount of circulating antibody.
• The role of drugs in the treatment of cerebral palsy.
• The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.
• [Calcium channel blockers in the treatment of arterial hypertension]